zidovudin natur histori acquir immunodefici syndrom background method trend surviv person acquir immunodefici syndrom aid rel effect natur histori aid zidovudin use demograph clinic characterist longitudin observ population-bas studi data maryland human immunodefici viru inform system data base inform maryland aid registri data public privat health care claim vital statist hospit long-term care ambulatori care record result median surviv diagnosi person aid day diagnos diagnos day person aid april zidovudin avail two-year surviv men women person year old person non-hispan white minor person categori human immunodefici viru transmiss homosexu contact heterosexu transfusion-rel common mode transmiss analys group surviv like zidovudin median surviv zidovudin day day drug proportional-hazard analysi zidovudin therapi factor improv surviv conclus maryland resid aid improv surviv zidovudin therapi aspect care improv surviv 